Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation

医学 二尖瓣反流 心脏病学 内科学 心房颤动 二尖瓣 射血分数 二尖瓣置换术 心室流出道 心室流出道梗阻 外科 心力衰竭
作者
John Saxon,Philippe Généreux,Vlasis Ninios,Thomas Waggoner,Naeem Tahirkheli,Marek Grygier,Krzysztof Wróbel,Matti Adam,Georg Nickenig,Tsuyoshi Kaneko,Paul Sorajja
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
卷期号:18 (4): e014985-e014985 被引量:7
标识
DOI:10.1161/circinterventions.124.014985
摘要

BACKGROUND: Many patients with atrial functional mitral regurgitation are not suitable candidates for surgery or transcatheter repair. For transcatheter mitral valve replacement, a common contraindication is the risk of left ventricular outflow tract obstruction, particularly in patients with atrial functional mitral regurgitation, who have characteristically small left ventricles. Herein, we examine the outcomes of transcatheter mitral valve replacement using the AltaValve system, which employs atrial fixation thus minimizing left ventricular outflow tract obstruction risk. METHODS: Patients with severe, symptomatic mitral regurgitation who were treated in the AltaValve early feasibility study or on the basis of a compassionate use exemption. The definition of atrial functional mitral regurgitation required the presence of: (1) severe mitral regurgitation; (2) atrial fibrillation; (3) normal left ventricular size; (4) left ventricular ejection fraction ≥50%; and (5) absence of organic mitral disease. Procedural outcomes, 30-day survival, and echo findings are reported. RESULTS: Fourteen patients (71% women, mean age 77.9 years, Society of Thoracic Surgeons Predicted Risk of Mortality score 5.4%) were treated, including 11 via transseptal delivery and 3 via a transapical approach. Technical success and mitral regurgitation reduction from severe to none/trace were achieved in all cases. There were no cases of left ventricular outflow tract obstruction. All-cause mortality at 30 days was 14% (2/14). Class III/IV New York Heart Association status was reduced from 79% at baseline to 0% at 30 days. At 30 days, 11 of 12 surviving patients had an available echocardiogram; mitral regurgitation severity was trace/none in 90.9% (10/11) and mild in 9.1% (1/11). CONCLUSIONS: The AltaValve system shows promising early procedural and clinical results for the unique anatomy of patients with atrial functional mitral regurgitation. Long-term clinical studies to demonstrate the benefit of this system are warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
小Z完成签到,获得积分10
2秒前
2秒前
xuliang完成签到,获得积分10
2秒前
3秒前
沐木发布了新的文献求助30
5秒前
yrz完成签到,获得积分20
6秒前
斯文败类的应助被xwx采纳,获得10
7秒前
徐丹枫发布了新的文献求助10
7秒前
7秒前
乌龙茶发布了新的文献求助10
7秒前
我是老大的应助被科研通管家采纳,获得10
7秒前
深情安青的应助被科研通管家采纳,获得10
8秒前
8秒前
FashionBoy的应助被科研通管家采纳,获得50
8秒前
情怀的应助被科研通管家采纳,获得10
8秒前
Hase的应助被科研通管家采纳,获得30
8秒前
秋风的应助被科研通管家采纳,获得10
8秒前
华仔的应助被科研通管家采纳,获得10
8秒前
酷波er的应助被科研通管家采纳,获得10
8秒前
CipherSage的应助被科研通管家采纳,获得20
9秒前
勤奋一一的应助被科研通管家采纳,获得10
9秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
9秒前
9秒前
王英霖的应助被科研通管家采纳,获得20
9秒前
秋风的应助被科研通管家采纳,获得20
9秒前
syvshc的应助被科研通管家采纳,获得10
9秒前
李爱国的应助被科研通管家采纳,获得10
9秒前
科研通AI2S的应助被科研通管家采纳,获得10
10秒前
Luna666完成签到,获得积分10
10秒前
乐乐的应助被科研通管家采纳,获得10
10秒前
10秒前
wanci的应助被科研通管家采纳,获得50
10秒前
10秒前
丁亦竹发布了新的文献求助100
11秒前
能干灯泡发布了新的文献求助10
12秒前
赘婿的应助被观山青采纳,获得10
12秒前
传奇3的应助被平常的路人采纳,获得10
12秒前
我家电脑完成签到 ,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181767
求助须知:如何正确求助?哪些是违规求助? 9571480
关于积分的说明 21818225
捐赠科研通 7778030
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479598